University of California at San Francisco researchers have built a protein profile test for breast cancer that predicts whether women with a breast-cancer precursor called ductal carcinoma will develop invasive breast cancer that requires aggressive treatment.

If the high-risk protein profiles become a standard test, people with low-risk profiles could be spared unnecessary surgery and drugs.